Periampullary Cancer ESPAC-3(v2) trial: a Randomised Controlled Phase III Trial of Adjuvant Chemotherapy Versus Observation in Patients With Periampullary Adenocarcinomas of the Head of the Pancreas

被引：0

作者：

Neoptolemos, J. ^{[1
]}

Moore, M.

Cox, T. ^{[1
]}

Valle, J. ^{[2
]}

Palmer, D. ^{[1
]}

Mcdonald, A. ^{[3
]}

Carter, R. ^{[4
]}

Tebbutt, N. ^{[5
]}

Dervenis, C. ^{[6
]}

Smith, D. ^{[1
]}

Glimelius, B. ^{[7
]}

Coxon, F. ^{[8
]}

Lacaine, F. ^{[9
]}

Middleton, M. ^{[10
]}

Ghaneh, P. ^{[1
]}

Bassi, C. ^{[11
]}

Halloran, C. ^{[1
]}

Olah, A. ^{[12
]}

Rawcliffe, C. ^{[1
]}

Buechler, M. ^{[13
]}

机构：

[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England

[2] Christie, Manchester, Lancs, England

[3] Univ Birmingham, Birmingham B15 2TT, W Midlands, England

[4] Glasgow Royal Infirm, Glasgow, Lanark, Scotland

[5] Austin Hosp, Heidelberg, Vic 3084, Australia

[6] Aiga Olga, Athens, Greece

[7] Univ Uppsala Hosp, Uppsala, Sweden

[8] No Canc Ctr, Newcastle Upon Tyne, Tyne & Wear, England

[9] Hosp Tenon, Paris, France

[10] John Radcliffe Hosp, Oxford OX3 9DU, England

[11] Univ Verona, I-37100 Verona, Italy

[12] Petz Aladar Hosp, Gyor, Hungary

[13] Univ Heidelberg, D-6900 Heidelberg, Germany

来源：

PANCREAS | 2011年 / 40卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1343 / 1343

页数：1

共 50 条

[31] Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial
Oshima, Takashi
Tsuburaya, Akira
Yoshida, Kazuhiro
Yoshikawa, Takaki
Miyagi, Yohei
Rino, Yasushi
Masuda, Munetaka
Guan, Jia
Tan, Patrick
Grabsch, Heike, I
Sakamoto, Junichi
Tanaka, Shiro
SCIENTIFIC REPORTS, 2022, 12 (01)
[32] Early versus conventional adjuvant chemotherapy in stage III colon cancer: A multicenter, randomized, open-label, phase 3 trial
Park, Soo Yeun
Kim, So Hyun
Lee, Kyung Ha
Song, Seung Ho
Kim, Hye Jin
Kim, Jong Gwang
Kang, Byung Woog
Baek, Seong Kyu
Jeong, Woon Kyung
Bae, Sung Uk
Lee, In Kyu
Lee, Yoon Suk
Son, Gyung Mo
Bae, Ki Beom
Kim, Ji Yeon
Park, Jun Seok
Choi, Gyu-Seog
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[33] Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial
Takashi Oshima
Akira Tsuburaya
Kazuhiro Yoshida
Takaki Yoshikawa
Yohei Miyagi
Yasushi Rino
Munetaka Masuda
Jia Guan
Patrick Tan
Heike I. Grabsch
Junichi Sakamoto
Shiro Tanaka
Scientific Reports, 12
[34] Examining personalized radiation therapy (EXPERT): A randomised phase III trial of adjuvant radiotherapy vs observation in patients with molecularly characterized luminal A breast cancer
Chua, B. H.
Gray, K.
Krishnasamy, M.
Regan, M.
Zdenkowski, N.
Loi, S.
Mann, B.
Forbes, J. F.
Wilcken, N.
Spillane, A.
Martin, A.
Badger, H.
Jafari, S.
Fong, A.
Mavin, C.
Corachan, S.
Arahmani, A.
Martinez, J-L
Francis, P.
CANCER RESEARCH, 2019, 79 (04)
[35] A phase III clinical trial of adjuvant chemotherapy versus chemoimmunotherapy for stage IB-IIIA completely resected non-small cell lung cancer (NSCLC) patients nadim-adjuvant: New adjuvant trial of chemotherapy versus chemoimmunotherapy.
Calvo, Virginia
Domine, Manuel
Sullivan, Ivana
Gonzalez-Larriba, Jose-Luis
Ortega, Ana Laura
Bernabe, Reyes
Sala, Maria Angeles
Campos, Begona
De Castro, Javier
Martin-Martorell, Paloma
Bosch-Barrera, Joaquim
Mielgo, Xabier
Vila, Laia
Casal, Joaquin
Ros, Silver
Aguillo, Maite Martinez
Padilla, Airam
Sandiego, Sergio
Machado, Jonathan Aires
Provencio-Pulla, Mariano
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[36] Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer
Cohen, Ezra E. W.
Karrison, Theodore G.
Kocherginsky, Masha
Mueller, Jeffrey
Egan, Robyn
Huang, Chao H.
Brockstein, Bruce E.
Agulnik, Mark B.
Mittal, Bharat B.
Yunus, Furhan
Samant, Sandeep
Raez, Luis E.
Mehra, Ranee
Kumar, Priya
Ondrey, Frank
Marchand, Patrice
Braegas, Bettina
Seiwert, Tanguy Y.
Villaflor, Victoria M.
Haraf, Daniel J.
Vokes, Everett E.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2735 - +
[37] Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
Kerr, Rachel S.
Love, Sharon
Segelov, Eva
Johnstone, Elaine
Falcon, Beverly
Hewett, Peter
Weaver, Andrew
Church, David
Scudder, Claire
Pearson, Sarah
Julier, Patrick
Pezzella, Francesco
Tomlinson, Ian
Domingo, Enric
Kerr, David J.
LANCET ONCOLOGY, 2016, 17 (11): : 1543 - 1557
[38] Quality of Life After Curative Resection for Rectal Cancer in Patients Treated With Adjuvant Chemotherapy Compared With Observation: Results of the Randomized Phase III SCRIPT Trial
van der Valk, Maxime J. M.
Hilling, Denise E.
Kranenbarg, Elma Meershoek-Klein
Peeters, Koen C. M. J.
Kapiteijn, Ellen
Tsonaka, Roula
van de Velde, Cornelis J. H.
Marang-van de Mheen, Perla J.
DISEASES OF THE COLON & RECTUM, 2019, 62 (06) : 711 - 720
[39] ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma.
Neoptolemos, John P.
Palmer, Dan
Ghaneh, Paula
Valle, Juan W.
Cunningham, David
Wadsley, Jonathan
Meyer, Tim
Anthoney, Alan
Glimelius, Bengt
Falk, Stephen
Segersvard, Ralf
Izbicki, Jakob R.
Middleton, Gary William
Ross, Paul J.
Wasan, Harpreet
Mcdonald, Alec
Crosby, Tom David Lewis
Psarelli, Eftychia Eirini
Hammel, Pascal
Buchler, Markus W.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (18)
[40] Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer. First results of a randomized phase III trial EORTC 10901
Paridaens, R.
Dyczka, J.
Rutgers, E. J. T.
Coleman, R.
Cufer, T.
Jassem, J.
Nortier, J. W. R.
Morales, L.
Mattiacci, M. R.
Therasse, P.
EJC SUPPLEMENTS, 2004, 2 (03): : 70 - 70

← 1 2 3 4 5 →